Literature DB >> 6101080

Opioid effects in developing rat vas deferens.

A Z Rónai1, I P Berzétei, J Kurgyis.   

Abstract

The inhibitory effects of various opiates on developing rat vas deferens were studied by determining the degree of depression of mechanical responses elicited by electrical field stimulation. All agonists showed decreased effects with maturation, but the decrease occurred at different times. With normorphine the loss of agonist activity was greatest at days 12-16, while with D-Met2,Pro5-enkephalinamide it was greatest at days 16-30. beta-Endorphin also was less effective in adult than 30-day preparations, but methionine enkephalin was ineffective at all ages. Morphine and normorphine were weak antagonists of opiate agonists in the adult preparations. These results indicate that the nature and pharmacologic sensitivity of opiate actions change with development.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6101080     DOI: 10.1007/bf00716268

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  13 in total

1.  Specificity of opioids towards the mu-, delta- and epsilon-opiate receptors.

Authors:  M Wüster; R Schulz; A Herz
Journal:  Neurosci Lett       Date:  1979-12       Impact factor: 3.046

2.  Ontological development of opiate receptors in rodent brain.

Authors:  N J Clendeninn; M Petraitis; E J Simon
Journal:  Brain Res       Date:  1976-12-10       Impact factor: 3.252

3.  Ontogenetic development of [3H]naloxone binding in rat brain.

Authors:  J T Coyle; C B Pert
Journal:  Neuropharmacology       Date:  1976-09       Impact factor: 5.250

4.  A superactive antinociceptive pentapeptide, (D-Met2, Pro5)-enkephalinamide.

Authors:  S Bajusz; A Z Rónai; J I Székely; L Gráf; Z Dunai-Kovács; I Berzétei
Journal:  FEBS Lett       Date:  1977-04-01       Impact factor: 4.124

5.  Perinatal development of the endorphin- and enkephalin-containing systems in the rat brain.

Authors:  A Bayon; W J Shoemaker; F E Bloom; A Mauss; R Guillemin
Journal:  Brain Res       Date:  1979-12-21       Impact factor: 3.252

6.  The in vitro pharmacology of D-Met2,Pro5-enkephalinamide.

Authors:  A Z Rónai; I P Berzétei; S Bajusz; J I Székely
Journal:  J Pharm Pharmacol       Date:  1981-08       Impact factor: 3.765

7.  Some quantitative uses of drug antagonists.

Authors:  O ARUNLAKSHANA; H O SCHILD
Journal:  Br J Pharmacol Chemother       Date:  1959-03

8.  Endogenous opioid peptides: multiple agonists and receptors.

Authors:  J A Lord; A A Waterfield; J Hughes; H W Kosterlitz
Journal:  Nature       Date:  1977-06-09       Impact factor: 49.962

9.  Kinetic parameters of narcotic agonists and antagonists, with particular reference to N-allylnoroxymorphone (naloxone).

Authors:  H W Kosterlitz; A J Watt
Journal:  Br J Pharmacol Chemother       Date:  1968-06

10.  Rat vas deferens: a specific bioassay for endogenous opioid peptides.

Authors:  S Lemaire; J Magnan; D Regoli
Journal:  Br J Pharmacol       Date:  1978-11       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.